31.1 C
Saturday, May 15, 2021

Cipla to scale up Remdesivir production 2-fold

- Advertisement -

Cipla to scale up Remdesivir production 2-foldNew Delhi, Apr 13 (IANS): Pharmaceutical company Cipla on Tuesday said it has scaled up the production of remdesivir by 2 times from the last wave of the pandemic.

As the demand for the drug surges, the government has prohibited the exports of remdesivir injection and its active pharmaceutical ingredients (API).

“Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network, to service the demand,” the company said in a statement.

“To ensure fair and equitable access, we are working with the regulatory authorities to restrict supply of the drug only to hospital channels and especially those regions with high burden of severe Covid-19,” Cipla said.

READ ALSO:  LS passes National Institutes of Design Amendment Bill

On Tocilizumab, the company said that given the spike in cases and surge in demand, it is facing a shortage and working closely with its partner in taking necessary steps to ensure availability of the drug.

“We expect intermittent supplies as the demand outstrips supply with some more receipts at the earliest,” it added.

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

READ ALSO:  Government slashes Remdesivir MRP by half, with retro-effect

Related News


Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India